199 related articles for article (PubMed ID: 205665)
21. EVB-associated immune complexes and recurrent Burkitt's lymphoma.
Gunven P; Klein G; Rosen A; Mukojima T
IARC Sci Publ (1971); 1978; (24 Pt 2):875-82. PubMed ID: 221409
[No Abstract] [Full Text] [Related]
22. Epstein-Barr virus-related serology in Hodgkin's disease.
Henle W; Henle G
Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
[No Abstract] [Full Text] [Related]
23. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma.
Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA
Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015
[TBL] [Abstract][Full Text] [Related]
24. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
Svedmyr A; Demissie A; Klein G; Clifford P
J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
[No Abstract] [Full Text] [Related]
25. Chromosome translocations, surface immunoglobulins, and Epstein-Barr virus in Japanese Burkitt's lymphoma.
Sakurai M; Hayashi Y; Abe R; Nakazawa S
Cancer Genet Cytogenet; 1983 Mar; 8(3):275-6. PubMed ID: 6297707
[No Abstract] [Full Text] [Related]
26. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
Gunvén P
Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070
[No Abstract] [Full Text] [Related]
27. An Epstein-Barr virus-negative B lymphoma cell line (THP-2) from a Burkitt's lymphoma of a Japanese patient.
Tsuchiya S; Yamaguchi Y; Kobayashi Y; Minegishi M; Imaizumi M; Suzuki H; Konno T; Tada K
Tohoku J Exp Med; 1983 Aug; 140(4):429-34. PubMed ID: 6314596
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus and Burkitt lymphoma.
Lancet; 1978 Sep; 2(8089):561. PubMed ID: 79925
[No Abstract] [Full Text] [Related]
29. Antinuclear antibodies and elevated anti-Epstein-Barr virus titers in cancer patients.
McCormick NK; McCormick KJ; Trentin JJ
Infect Immun; 1976 May; 13(5):1382-6. PubMed ID: 178605
[TBL] [Abstract][Full Text] [Related]
30. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease.
Stepina VN; Gourtsevicz VE; Mazurenko NP; Yarymova NM; Kaverznyeva MM; Lorye YI
Neoplasma; 1976; 23(5):523-32. PubMed ID: 185535
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS
J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407
[TBL] [Abstract][Full Text] [Related]
32. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.
Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R
J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787
[TBL] [Abstract][Full Text] [Related]
33. Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients.
Biggar RJ; Pandey JP; Henle W; Nkrumah FK; Levine PH
Int J Cancer; 1984 May; 33(5):577-80. PubMed ID: 6327537
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.
de-Thé G; Geser A; Day NE; Tukei PM; Williams EH; Beri DP; Smith PG; Dean AG; Bronkamm GW; Feorino P; Henle W
Nature; 1978 Aug; 274(5673):756-61. PubMed ID: 210392
[TBL] [Abstract][Full Text] [Related]
35. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to Epstein-Barr viral capsid and early antigens associated with Burkitt's lymphoma and lymphoblastic lymphosarcoma in Israel.
Gotleib-Stematsky T; Ramot B; Vonsover B; Aghai E; Kende G; Ninio M; Modan M
J Natl Cancer Inst; 1976 Apr; 56(4):721-3. PubMed ID: 233958
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
Gunvén P; Klein G; Henle G; Henle W; Clifford P
Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
[No Abstract] [Full Text] [Related]
38. A case of malignant lymphoma, undifferentiated, Burkitt's type with high antibodies to Epstein-Barr virus.
Chen W; Yang KC; Shih JS; Hsu CA; Yeh YS; Chen TY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Sep; 13(3):343-9. PubMed ID: 6265160
[TBL] [Abstract][Full Text] [Related]
39. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies.
Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G
J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908
[TBL] [Abstract][Full Text] [Related]
40. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
